rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
The association between BDNF Val66Met and SI was modeled using logistic regression adjusted for age and sex, and in secondary analyses also for depression.
|
30329132 |
2020 |
rs759834365
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
The association between BDNF Val66Met and SI was modeled using logistic regression adjusted for age and sex, and in secondary analyses also for depression.
|
30329132 |
2020 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
Plasma brain-derived neurotrophic factor (BDNF) concentration and the <i>BDNF</i> Val66Met polymorphism in suicide: a prospective study in patients with depressive disorder.
|
31308724 |
2019 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
The BDNF Val66Met contributed to the severity of CSI even after adjusting to PTSD, depression and LEC.
|
30904785 |
2019 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
The combination of disadvantageous allelic expression of rs6295 and rs6265 may result in a 5-HT<sub>1A</sub> receptor profile comparable to affective disorders as increased 5-HT<sub>1A</sub> receptor binding is a well published phenotype of depression.
|
30664620 |
2019 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
Our objectives were to: 1) compare plasma BDNF levels in medicated patients with depression and controls; 2) assess the effect of ECT on plasma BDNF levels in medicated patients with depression; 3) explore the relationship between plasma BDNF levels and the Val66Met (rs6265) BDNF polymorphism; and 4) examine the relationship between plasma BDNF levels and clinical symptoms and outcomes with ECT.
|
29802070 |
2019 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
Childhood adversity showed an interaction with the brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism, serotonin transporter-linked promoter region (5-HTTLPR), and FK506 binding protein 51 (FKBP5) gene rs1360780 in brain morphologic changes in patients with depression and in a non-clinical population.
|
29535036 |
2019 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
The Val66Met polymorphism did not appear to predict BDNF levels, depression incidence, or modify the relationship between dietary quality and BDNF.
|
29280414 |
2019 |
rs759834365
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
The Val66Met polymorphism did not appear to predict BDNF levels, depression incidence, or modify the relationship between dietary quality and BDNF.
|
29280414 |
2019 |
rs759834365
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
Our objectives were to: 1) compare plasma BDNF levels in medicated patients with depression and controls; 2) assess the effect of ECT on plasma BDNF levels in medicated patients with depression; 3) explore the relationship between plasma BDNF levels and the Val66Met (rs6265) BDNF polymorphism; and 4) examine the relationship between plasma BDNF levels and clinical symptoms and outcomes with ECT.
|
29802070 |
2019 |
rs759834365
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
The BDNF Val66Met contributed to the severity of CSI even after adjusting to PTSD, depression and LEC.
|
30904785 |
2019 |
rs759834365
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
Plasma brain-derived neurotrophic factor (BDNF) concentration and the <i>BDNF</i> Val66Met polymorphism in suicide: a prospective study in patients with depressive disorder.
|
31308724 |
2019 |
rs759834365
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
Childhood adversity showed an interaction with the brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism, serotonin transporter-linked promoter region (5-HTTLPR), and FK506 binding protein 51 (FKBP5) gene rs1360780 in brain morphologic changes in patients with depression and in a non-clinical population.
|
29535036 |
2019 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
|
29331787 |
2018 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
This study was to examine the chronic stress × BDNF Val66Met</span> interaction in job-related depression in the healthcare workers in a Chinese Han population, which has not been reported yet.
|
29734099 |
2018 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
We found evidence that supported the hypothesis that BDNF Val66Met polymorphism moderated the relationship between stress and depression, despite the fact that many included individual studies did not show this effect.
|
29102837 |
2018 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
Further studies are needed to evaluate the associations between rs6265 and poststroke depression, especially in Caucasians, with large sample size.
|
29449128 |
2018 |
rs759834365
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
|
29331787 |
2018 |
rs759834365
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
This study was to examine the chronic stress × BDNF Val66Met</span> interaction in job-related depression in the healthcare workers in a Chinese Han population, which has not been reported yet.
|
29734099 |
2018 |
rs759834365
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
We found evidence that supported the hypothesis that BDNF Val66Met polymorphism moderated the relationship between stress and depression, despite the fact that many included individual studies did not show this effect.
|
29102837 |
2018 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
However, one specific set of genes, the brain derived neurotrophic factor (BDNF), specifically the Val66Met polymorphism, may play a crucial role in AD-related depression.
|
27335045 |
2017 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
The present findings indicate the gender differences in the effect of Val66Met genotype on the cortisol responses to stress protocol, and extend the evidence for the importance of gender and the role of Val66Met in the modulation of stress reactivity and subsequent depression prevalence.
|
28249185 |
2017 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
To examine the effect of seasonality and rs6265 genotype on depression outcome and brain-derived neurotrophic factor (BDNF) level with dermatitis patients from onset through remission.
|
27409526 |
2017 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
The results suggest that interactions may occur after stresses among BDNF Val66Met, gender and time course to influence dep</span>ression.
|
28527683 |
2017 |
rs6265
|
BDNF;BDNF-AS
|
Depressive disorder
|
|
0.100 |
GeneticVariation |
BEFREE |
Association of BDNF Val66MET Polymorphism With Parkinson's Disease and Depression and Anxiety Symptoms.
|
27852165 |
2017 |